Sartorius Stedim Biotech header image

Sartorius Stedim Biotech

DIM

Equity

ISIN FR0013154002 / Valor 32518471

Euronext - Euronext Paris (2026-07-03)
EUR 180.20-1.04%

Sartorius Stedim Biotech
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Sartorius Stedim Biotech is a prominent global player in the biopharmaceutical industry, specializing in the development and manufacturing of biotech medications and vaccines. With a workforce of approximately 9,900 employees and operations in over 30 countries, the company provides a comprehensive range of products and technologies that support all critical stages of biopharmaceutical production and process development. Its offerings include cell line technologies, cell culture media, bioreactors, and various solutions for the separation, purification, and concentration of biological intermediates and finished products, as well as their storage and transportation. Headquartered in Aubagne, France, Sartorius Stedim Biotech is a subsidiary of Sartorius AG, which holds a significant majority of its share capital and voting rights. The company is publicly traded on the Euronext stock exchange in Paris.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-11.7%1Y
-21.2%3Y
-54.5%5Y

Performance

38.9%1Y
44.8%3Y
44.3%5Y

Volatility

Market cap

20060 M

Market cap (USD)

Daily traded volume (Shares)

36,894

Daily traded volume (Shares)

1 day high/low

187.35 / 183.25

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.33%CHF 359.40
2invest AG
2invest AG 2invest AG Valor: 110098281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.20%EUR 8.38
Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited Emcure Pharmaceuticals Limited Valor: 136422285
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.94%INR 1,837.10
CorVel Corp
CorVel Corp CorVel Corp Valor: 921843
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.54%USD 64.14
Teladoc Health Inc
Teladoc Health Inc Teladoc Health Inc Valor: 28438140
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.10%USD 9.20
Rubicon Research Limited
Rubicon Research Limited Rubicon Research Limited Valor: 149582844
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.22%INR 1,302.75
Penumbra Inc
Penumbra Inc Penumbra Inc Valor: 29290920
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.68%USD 318.57
Basilea Pharmaceutica Ltd, Allschwil
Basilea Pharmaceutica Ltd, Allschwil Basilea Pharmaceutica Ltd, Allschwil Valor: 1143244
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.26%CHF 54.30
DocMorris Ltd
DocMorris Ltd DocMorris Ltd Valor: 4261528
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.65%CHF 9.25
Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited Dr. Lal PathLabs Limited Valor: 30691066
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.37%INR 1,646.15